HCPCS Level II
J9331
Injection, sirolimus protein-bound particles, 1 mg
Codes near J9331
These sit next to J9331 in the CMS Level II file. All J codes
- J9325Injection, talimogene laherparepvec, per 1 million plaque forming units
- J9326Injection, telisotuzumab vedotin-tllv, 1 mg
- J9328Injection, temozolomide, 1 mg
- J9329Injection, tislelizumab-jsgr, 1mg
- J9330Injection, temsirolimus, 1 mg
- J9332Injection, efgartigimod alfa-fcab, 2mg
- J9333Injection, rozanolixizumab-noli, 1 mg
- J9334Injection, efgartigimod alfa, 2 mg and hyaluronidase-qvfc
- J9340Injection, thiotepa, 15 mg
- J9341Injection, thiotepa (tepylute), 1 mg
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 80803-0153-50 | Fyarro | Aadi Bioscience | 100 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.